Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer

Yuning Liao(Guangzhou Medical University), Hongbiao Huang(Harbin Institute of Technology)
Journal of Experimental & Clinical Cancer Research
April 11, 2019
Cited by 101


Related Papers